No association between the deltaF508 cystic fibrosis mutation and type 2 diabetes mellitus

J Braun1, J Arnemann, M Lohrey

  • 1Medical Clinic I, Department of Endocrinology, University of Frankfurt/Main, Germany.

Insights

Heterozygosity for the deltaF508 mutation, common in cystic fibrosis (CF), was investigated as a risk factor for type 2 diabetes. This study found no significant association, indicating deltaF508 is not a major genetic risk factor for type 2 diabetes.

Area of Science:

  • Genetics and Human Health
  • Metabolic Disorders

Background:

  • Cystic fibrosis (CF) is a common inherited disorder caused by CFTR gene mutations.
  • The deltaF508 mutation is the most prevalent CF mutation.
  • Increased type 2 diabetes mellitus (T2DM) incidence in CF relatives suggests a potential genetic link.

Purpose of the Study:

  • To investigate if heterozygosity for the deltaF508 mutation is a genetic risk factor for T2DM.
  • To evaluate the prevalence of deltaF508 heterozygotes in T2DM patients and healthy controls.

Main Methods:

  • Genotyping analysis was performed on 301 T2DM patients and 282 healthy controls.
  • Patients with T2DM had received treatment for at least three years.
  • Controls had no family history of diabetes.

Main Results:

  • The genotype distribution of deltaF508 heterozygotes did not significantly differ between T2DM patients (2%) and controls (3%).
  • These findings suggest a lack of association between deltaF508 heterozygosity and T2DM.

Conclusions:

  • Heterozygosity for the deltaF508 mutation is not a major genetic risk factor for type 2 diabetes mellitus.
  • Further research may explore other genetic or environmental factors contributing to T2DM in CF-related populations.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...